Perspectives in Psychopharmacology
This section contains a compilation of recent publications that have shaped the thinking in the field as well as classic works that remain important to the subject reviewed in this issue. This bibliography has been compiled by experts in the field and members of the editorial and advisory boards. Entries are listed chronologically by first author. Articles from the bibliography that are reprinted in this issue are in bold type.
2020
Anderson KN, Lind JN, Simeone RM, et al: Maternal use of specific antidepressant medications during early pregnancy and the risk of selected birth defects. JAMA Psychiatry 2020; e202453
Cuijpers P, Noma H, Karyotaki E, et al: A network meta-analysis of the effects of psychotherapies, pharmacotherapies and their combination in the treatment of adult depression. World Psychiatry 2020; 19:92–107
Fagiolini A, Alcalá JÁ, Aubel T, et al: Treating schizophrenia with cariprazine: from clinical research to clinical practice. Real world experiences and recommendations from an International Panel. Ann Gen Psychiatry 2020; 19:55
Faraone SV, Rostain AL, Montano CB, et al: Systematic review: nonmedical use of prescription stimulants: risk factors, outcomes, and risk reduction strategies. J Am Acad Child Adolesc Psychiatry 2020; 59:100–112
Forester BP, Parikh SV, Weisenbach S, et al: Combinatorial pharmacogenomic testing improves outcomes for older adults with depression. Am J Geriatr Psychiatry 2020; 28:933–945
Gerhard T, Stroup TS, Correll CU, et al: Mortality risk of antipsychotic augmentation for adult depression. PLoS One 2020; 15:e0239206
Jiang WL, Cai DB, Yin F, et al: Adjunctive metformin for antipsychotic-induced dyslipidemia: a meta-analysis of randomized, double-blind, placebo-controlled trials. Transl Psychiatry 2020; 10:117
Kim N, McCarthy DE, Piper ME, et al: Comparative effects of varenicline or combination nicotine replacement therapy versus patch monotherapy on candidate mediators of early abstinence in a smoking cessation attempt. Addiction (ahead of print, Sept 4, 2020).
Leone FT, Zhang Y, Evers-Casey S, et al: Initiating Pharmacologic Treatment in Tobacco-Dependent Adults: An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med 2020; 202:e5–e31
Rakofsky JJ, Talbot TB, Dunlop BW: A virtual standardized patient-based assessment tool to evaluate psychiatric residents’ psychopharmacology proficiency. Acad Psychiatry 2020; 44:693–700
Reiff CM, Richman EE, Nemeroff CB, et al: Psychedelics and psychedelic-assisted psychotherapy. Am J Psychiatry 2020; 177:391–410
Solmi M, Fornaro M, Ostinelli EG, et al: Safety of 80 antidepressants, antipsychotics, anti-attention-deficit/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic meta-review of 78 adverse effects. World Psychiatry 2020; 19:214–232
Yoshida K, Müller DJ: Pharmacogenetics of antipsychotic drug treatment: update and clinical implications. Mol Neuropsychiatry 2020; 5(Suppl 1):1–26
2019
Chang Z, Ghirardi L, Quinn PD, et al: Risks and benefits of attention-deficit/hyperactivity disorder medication on behavioral and neuropsychiatric outcomes: a qualitative review of pharmacoepidemiology studies using linked prescription databases. Biol Psychiatry 2019; 86:335–343
Corponi F, Fabbri C, Bitter I, et al: Novel antipsychotics specificity profile: a clinically oriented review of lurasidone, brexpiprazole, cariprazine and lumateperone. Eur Neuropsychopharmacol 2019; 29:971–985
Earley W, Burgess MV, Rekeda L, et al: Cariprazine treatment of bipolar depression: a randomized double-blind placebo-controlled phase 3 study. Am J Psychiatry 2019; 176:439–448
Factor SA, Burkhard PR, Caroff S, et al: Recent developments in drug-induced movement disorders: a mixed picture. Lancet Neurol 2019; 18:880–890
Furukawa TA, Cipriani A, Cowen PJ, et al: Optimal dose of selective serotonin reuptake inhibitors, venlafaxine, and mirtazapine in major depression: a systematic review and dose-response meta-analysis. Lancet Psychiatry 2019; 6:601–609
Huhn M, Nikolakopoulou A, Schneider-Thoma J, et al: Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis. Lancet 2019; 394:939–951
Kingsberg SA, Clayton AH, Portman D, et al: Bremelanotide for the treatment of hypoactive sexual desire disorder: two randomized phase 3 trials. Obstet Gynecol 2019; 134:899–908
Pardis P, Remington G, Panda R, et al: Clozapine and tardive dyskinesia in patients with schizophrenia: a systematic review. J Psychopharmacol 2019; 33:1187–1198
Vancampfort D, Firth J, Correll CU, et al: The impact of pharmacological and non-pharmacological interventions to improve physical health outcomes in people with schizophrenia: a meta-review of meta-analyses of randomized controlled trials. World Psychiatry 2019; 18:53–66
Waxmonsky JG, Pelham WE III, Campa A, et al: A randomized controlled trial of interventions for growth suppression in children with attention-deficit/hyperactivity disorder treated with central nervous system stimulants. J Am Acad Child Adolesc Psychiatry 2020; 59:1330–1341
Wolraich ML, Hagan JF Jr, Allan C, et al: Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents. Pediatrics 2019; 144:e20192528
2018
Clayton AH, Goldstein I, Kim NN, et al: The International Society for the Study of Women’s Sexual Health process of care for management of hypoactive sexual desire disorder in women. Mayo Clin Proc 2018; 93:467–487
Cortese S, Adamo N, Del Giovane C, et al: Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. Lancet Psychiatry 2018; 5:727–738
Mentzel TQ, van der Snoek R, Lieverse R, et al: Clozapine monotherapy as a treatment for antipsychotic-induced tardive dyskinesia: a meta-analysis. J Clin Psychiatry 2018; 79:17r11852
Solmi M, Pigato G, Kane JM, et al: Treatment of tardive dyskinesia with VMAT-2 inhibitors: a systematic review and meta-analysis of randomized controlled trials. Drug Des Devel Ther 2018; 12:1215–1238
Walshaw PD, Gyulai L, Bauer M, et al: Adjunctive thyroid hormone treatment in rapid cycling bipolar disorder: a double-blind placebo-controlled trial of levothyroxine (L-T4) and triiodothyronine (T3). Bipolar Disord 2018; 20:594–603
Further Reading
Carbon M, Hsieh CH, Kane JM, et al: Tardive dyskinesia prevalence in the period of second-generation antipsychotic use: a meta-analysis. J Clin Psychiatry 2017; 78:e264–e278
Fernandez HH, Factor SA, Hauser RA, et al: Randomized controlled trial of deutetrabenazine for tardive dyskinesia: the ARM-TD study. Neurology 2017; 88:2003–2010
Hauser RA, Factor SA, Marder SR, et al: KINECT 3: a phase 3 randomized, double-blind, placebo-controlled trial of valbenazine for tardive dyskinesia. Am J Psychiatry 2017; 174:476–484
Kanes S, Colquhoun H, Gunduz-Bruce H, et al: Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial. Lancet 2017; 390:480–489
Liu B, Zhang Y, Fang H, et al: Efficacy and safety of long-term antidepressant treatment for bipolar disorders: a meta-analysis of randomized controlled trials. J Affect Disord 2017; 223:41–48
McGirr A, Vöhringer PA, Ghaemi SN, et al: Safety and efficacy of adjunctive second-generation antidepressant therapy with a mood stabiliser or an atypical antipsychotic in acute bipolar depression: a systematic review and meta-analysis of randomised placebo-controlled trials. Lancet Psychiatry 2016; 3:1138–1146
Information & Authors
Information
Published In
History
Published in print: Winter 2021
Published online: 28 January 2021
Authors
Metrics & Citations
Metrics
Citations
Export Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.
For more information or tips please see 'Downloading to a citation manager' in the Help menu.
View Options
View options
PDF/EPUB
View PDF/EPUBGet Access
Login options
Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.
Personal login Institutional Login Open Athens loginNot a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).